A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.

Frye, M A; Ketter, T A; Kimbrell, T A; Dunn, R T; Speer, A M; Osuch, E A; Luckenbaugh, D A; Cora-Ocatelli, G; Leverich, G S; Post, R M

Frye, M A; Ketter, T A; Kimbrell, T A; Dunn, R T; Speer, A M; Osuch, E A; Luckenbaugh, D A; Cora-Ocatelli, G; Leverich, G S; Post, R M.

Affiliation

Frye MA; Biological Psychiatry Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892-1272, USA.

J Clin Psychopharmacol ; 20(6): 607-14, 2000 Dec.

Article in En | MEDLINE | ID: mdl-11106131

Subject(s)

Acetates/therapeutic use; Amines; Antimanic Agents/therapeutic use; Cyclohexanecarboxylic Acids; Mood Disorders/drug therapy; Triazines/therapeutic use; gamma-Aminobutyric Acid; Adult; Cross-Over Studies; Double-Blind Method; Female; Gabapentin; Humans; Lamotrigine; Male; Middle Aged; Mood Disorders/psychology; Placebos; Psychiatric Status Rating Scales; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Triazines / Antimanic Agents / Mood Disorders / Cyclohexanecarboxylic Acids / Gamma-Aminobutyric Acid / Amines / Acetates Type of study: Clinical_trials Language: En Journal: J Clin Psychopharmacol Year: 2000 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links